Recurrence of cholestatic liver disease after living donor liver transplantation

World Journal of Gastroenterology

Volumn 14, Issue 33, 2008, Pages 5105-5109

  Tamura, Sumihito ^a   Sugawara, Yasuhiko ^a   Kaneko, Junichi ^a   Togashi, Junichi ^a   Matsui, Yuichi ^a   Yamashiki, Noriyo ^a   Kokudo, Norihiro ^a   Makuuchi, Masatoshi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPANESE RED CROSS MEDICAL CENTER   (Japan)

Author keywords

Liver transplantation; Living donor; Primary biliary cirrhosis; Primary sclerosing cholangitis; Recurrence

Indexed keywords

HLA ANTIGEN; MITOCHONDRION ANTIBODY;

BLOOD GROUP ABO INCOMPATIBILITY; GENETIC ASSOCIATION; GRAFT FAILURE; GRAFT SURVIVAL; HAPLOTYPE; HUMAN; LIFE EXPECTANCY; LIVER TRANSPLANTATION; LIVING DONOR; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; QUALITY OF LIFE; RECURRENCE RISK; RECURRENT DISEASE; RETRANSPLANTATION; REVIEW; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT RESPONSE; BILIARY CIRRHOSIS; CHOLESTASIS; SCLEROSING CHOLANGITIS; TREATMENT OUTCOME;

CHOLANGITIS, SCLEROSING; CHOLESTASIS; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; LIVING DONORS; RECURRENCE; TREATMENT OUTCOME;

EID: 58149218711     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5105     Document Type: Review

References (48)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-1580
2. Angulo P, Lindor KD. Primary sclerosing cholangitis. Hepatology 1999; 30: 325-332
3. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332: 924-933
4. Portincasa P, Vacca M, Moschetta A, Petruzzelli M, Palasciano G, van Erpecum KJ, van Berge-Henegouwen GP. Primary sclerosing cholangitis: updates in diagnosis and therapy. World J Gastroenterol 2005; 11: 7-16
5. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273
6. Lindor K. Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. N Engl J Med 2007; 357: 1524-1529
7. Corpechot C, Carrat F, Bahr A, Chretien Y, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 2005; 128: 297-303
8. LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology 2006; 44: 746-764
9. Faust TW. Recurrent primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis after transplantation. Liver Transpl 2001; 7: S99-S108
10. Sugawara Y, Makuuchi M. Technical advances in living-related liver transplantation. J Hepatobiliary Pancreat Surg 1999; 6: 245-253
11. Imamura H, Makuuchi M, Sakamoto Y, Sugawara Y, Sano K, Nakayama A, Kawasaki S, Takayama T. Anatomical keys and pitfalls in living donor liver transplantation. J Hepatobiliary Pancreat Surg 2000; 7: 380-394
12. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, Kiyosawa K, Ichida T. Successful living-related partial liver transplantation to an adult patient. Lancet 1994; 343: 1233-1234
13. Yamashiki N, Sugawara Y, Tamura S, Kaneko J, Nojiri K, Omata M, Makuuchi M. Selection of liver-transplant candidates for adult-to-adult living donor liver transplantation as the only surgical option for end-stage liver disease. Liver Transpl 2006; 12: 1077-1083
14. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. The survival benefit of liver transplantation. Am J Transplant 2005; 5: 307-313
15. Neuberger J. Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence. J Hepatol 2003; 39: 142-148
16. Navasa M, Forns X, Sanchez V, Andreu H, Marcos V, Borras JM, Rimola A, Grande L, Garcia-Valdecasas JC, Granados A, Rodes J. Quality of life, major medical complications and hospital service utilization in patients with primary biliary cirrhosis after liver transplantation. J Hepatol 1996; 25: 129-134
17. Murtaugh PA, Dickson ER, Van Dam GM, Malinchoc M, Grambsch PM, Langworthy AL, Gips CH. Primary biliary cirrhosis: prediction of short-term survival based on repeated patient visits. Hepatology 1994; 20: 126-134
18. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MK, Evans RW, Klintmalm GB, Crippin JS, Krom RA, Dickson ER. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998; 28: 33-38
19. Kim WR, Wiesner RH, Poterucha JJ, Therneau TM, Benson JT, Krom RA, Dickson ER. Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. Liver Transpl 2000; 6: 489-494
20. Sugawara Y, Makuuchi M, Takayama T, Imamura H. Living-related liver transplantation for primary biliary cirrhosis. Transplantation 2001; 72: 1087-1091
21. Hasegawa K, Sugawara Y, Imamura H, Ikeda M, Kokudo N, Makuuchi M. Living donor liver transplantation for primary biliary cirrhosis: retrospective analysis of 50 patients in a single center. Transpl Int 2005; 18: 794-799
22. Liermann Garcia RF, Evangelista Garcia C, McMaster P, Neuberger J. Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center. Hepatology 2001; 33: 22-27
23. Hubscher SG, Elias E, Buckels JA, Mayer AD, McMaster P, Neuberger JM. Primary biliary cirrhosis. Histological evidence of disease recurrence after liver transplantation. J Hepatol 1993; 18: 173-184
24. Hashimoto E, Shimada M, Noguchi S, Taniai M, Tokushige K, Hayashi N, Takasaki K, Fuchinoue S, Ludwig J. Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study. Liver Transpl 2001; 7: 588-595
25. Morioka D, Egawa H, Kasahara M, Jo T, Sakamoto S, Ogura Y, Haga H, Takada Y, Shimada H, Tanaka K. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 80-90
26. Hashimoto T, Sugawara Y, Makuuchi M. Impact of human leukocyte antigen mismatching on outcomes of living donor liver transplantation for primary biliary cirrhosis. Liver Transpl 2007; 13: 938-939
27. Yamagiwa S, Ichida T. Recurrence of primary biliary cirrhosis and primary sclerosing cholangitis after liver transplantation in Japan. Hepatol Res 2007; 37 Suppl 3: S449-S454
28. Kim WR, Poterucha JJ, Wiesner RH, LaRusso NF, Lindor KD, Petz J, Therneau TM, Malinchoc M, Dickson ER. The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. Hepatology 1999; 29: 1643-1648
29. Graziadei IW, Wiesner RH, Batts KP, Marotta PJ, LaRusso NF, Porayko MK, Hay JE, Gores GJ, Charlton MR, Ludwig J, Poterucha JJ, Steers JL, Krom RA. Recurrence of primary sclerosing cholangitis following liver transplantation. Hepatology 1999; 29: 1050-1056
30. Kita Y, Lake JR, Ferrell LD, Mori M, Roberts JP, Kakizoe S, Kiyosawa K, Tanaka E, Shiga J, Takikawa H, Inoue Y, Ohtake T, Ohtomo K, Yotsuyanagi H, Oka T, Harihara Y, Takayama T, Kubota K, Kawarasaki H, Hashikura Y, Kawasaki S, Ascher NL, Makuuchi M. Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: report of a case. Transplant Proc 1998; 30: 3321-3323
31. Oya H, Sato Y, Yamamoto S, Takeishi T, Kobayashi T, Hatakeyama K. Living related donor liver transplantation for primary sclerosing cholangitis with hepatocellular carcinoma and Crohn's disease: a case report. Transplant Proc 2004; 36: 2297-2298
32. Kaibori M, Uemoto S, Fujita S, Inomata Y, Egawa H, Asonuma K, Kiuchi T, Hayashi M, Nakamura M, Tanaka K. Native hepatectomy after auxiliary partial orthotopic liver transplantation. Transpl Int 1999; 12: 383-386
33. Ikegami T, Nishizaki T, Yanaga K, Kakizoe S, Nomoto K, Ohta R, Minagawa R, Sugimachi K. Living-related auxiliary partial orthotopic liver transplantation for primary sclerosing cholangitis - subsequent removal of the native liver. Hepatogastroenterology 1999; 46: 2951-2954
34. Nakamura M, Fuchinoue S, Nakajima I, Kitajima K, Tojimbara T, Takasaki K, Shiraga H, Ito K, Tanaka K, Agishi T. Three cases of sequential liver-kidney transplantation from living-related donors. Nephrol Dial Transplant 2001; 16: 166-168
35. Varotti G, Gondolesi GE, Roayaie S, Suriawinata A, Soltys K, Fishbein TM, Schwartz ME, Miller C. Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis. J Am Coll Surg 2003; 197: 765-769
36. Akyildiz M, Karasu Z, Cagirgan S, Kilic M, Tokat Y. Rituximab therapy for life-threatining immune hemolytic anemia in a liver transplant recipient: a case report. Transplant Proc 2004; 36: 1492-1493
37. Wachs ME, Bak TE, Karrer FM, Everson GT, Shrestha R, Trouillot TE, Mandell MS, Steinberg TG, Kam I. Adult living donor liver transplantation using a right hepatic lobe. Transplantation 1998; 66: 1313-1316
38. Jabbour N, Gagandeep S, Mateo R, Sher L, Henderson R, Selby R, Genyk Y. Live donor liver transplantation: staging hepatectomy in a Jehovah's Witness recipient. J Hepatobiliary Pancreat Surg 2004; 11: 211-214
39. Heimbach JK, Menon KV, Ishitani MB, Nyberg SL, Jankowski CJ, Lindor KD, Rosen CB. Living donor liver transplantation using a right lobe graft in an adult with situs inversus. Liver Transpl 2005; 11: 111-113
40. Moon DB, Lee SG. Adult-to-adult living donor liver transplantation at the Asan Medical Center. Yonsei Med J 2004; 45: 1162-1168
41. Soejima Y, Harada N, Shimada M, Suehiro T, Minagawa R, Hiroshige S, Ninomiya M, Shiotani S, Nishizaki T. Perioperative management and complications in donors related to living-donor liver transplantation. Surgery 2002; 131: S195-S199
42. Solano E, Khakhar A, Bloch M, Quan D, McAlister V, Ghent C, Wall W, Marotta P. Liver transplantation for primary sclerosing cholangitis. Transplant Proc 2003; 35: 2431-2434
43. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003; 9: 737-740
44. Maheshwari A, Yoo HY, Thuluvath PJ. Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 2004; 99: 538-542
45. Bjoro K, Friman S, Hockerstedt K, Kirkegaard P, Keiding S, Schrumpf E, Olausson M, Oksanen A, Isoniemi H, Hjortrup A, Bergan A, Ericzon BG. Liver transplantation in the Nordic countries, 1982-1998: changes of indications and improving results. Scand J Gastroenterol 1999; 34: 714-722
46. http://jlts.umin.ac.jp/Registry(2005).pdf
47. Tamura S, Sugawara Y, Kaneko J, Matsui Y, Togashi J, Makuuchi M. Recurrence of primary sclerosing cholangitis after living donor liver transplantation. Liver Int 2007; 27: 86-94
48. Haga H, Miyagawa-Hayashino A, Taira K, Morioka D, Egawa H, Takada Y, Manabe T, Uemoto S. Histological recurrence of autoimmune liver diseases after living-donor liver transplantation. Hepatol Res 2007; 37 Suppl 3: S463-S469